AI in Action E138: Carsten Ullrich, Director of AI at Centogene

,  | October 23 2020 | Mark Kelly

Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.

Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.

In the show, Carsten will discuss:

His 20 years of experience working in AI 

How Centogene are applying AI in rare diseases 

Challenges they need to overcome, such as data quality 

Improving diagnostics and leveraging this for new discoveries 

What makes Centogene a great place to work 

Their work with COVID-19 Testing 

The possibility of AI with Superhuman capabilities  

To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.

What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.

Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.

Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.

Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.

In the show, Carsten will discuss:

His 20 years of experience working in AI 

How Centogene are applying AI in rare diseases 

Challenges they need to overcome, such as data quality 

Improving diagnostics and leveraging this for new discoveries 

What makes Centogene a great place to work 

Their work with COVID-19 Testing 

The possibility of AI with Superhuman capabilities  

To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.

What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.

If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.

Subscribe to The Alldus Podcast:

related podcasts

ServiceNow Series E174: Patrick Wilson, Director of Software Engineering at ServiceNow

 Welcome to episode 174 in our Digital Transformation series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being…

Read More

AI in Action E534: Patrick Elder, Director of Data & AI Centre of Excellence at ECS

 Welcome to episode 534 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives. Powered by Alldus International, our goal is to share with you the insights of technologists and data science…

Read More

Women in ServiceNow Series E01: Aly Skidmore, ServiceNow Platform Owner at abrdn

 Welcome to the very first episode in our Women in ServiceNow series Alldus podcast, a brand new series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the…

Read More